Literature DB >> 30362549

The role of iron metabolism in cancer therapy focusing on tumor-associated macrophages.

Dandan Dong1,2, Gejing Zhang1,2, Jiancheng Yang1,2, Bin Zhao1,2, Shenghang Wang1,2, Luyao Wang3, Ge Zhang3, Peng Shang4,2.   

Abstract

Iron is an essential micronutrient in mammalian cells for basic processes such as DNA synthesis, cell cycle progression, and mitochondrial activity. Macrophages play a vital role in iron metabolism, which is tightly linked to their phagocytosis of senescent and death erythrocytes. It is now recognized that the polarization process of macrophages determines the expression profile of genes associated with iron metabolism. Although iron metabolism is strictly controlled by physiology, cancer has recently been connected with disordered iron metabolism. Moreover, in the environment of cancer, tumor-associated macrophages (TAMs) exhibit an iron release phenotype, which stimulates tumor cell survival and growth. Usually, the abundance of TAMs in the tumor is implicated in poor disease prognosis. Therefore, important attention has been drawn toward the development of tumor immunotherapies targeting these TAMs focussing on iron metabolism and reprogramming polarized phenotypes. Although further systematic research is still required, these efforts are almost certainly valuable in the search for new and effective cancer treatments.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  TAMs; cancer therapy; iron metabolism; macrophages polarization; tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 30362549     DOI: 10.1002/jcp.27569

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

Review 1.  The role of iron homeostasis and iron-mediated ROS in cancer.

Authors:  Jia-Fu Ying; Ze-Bei Lu; Luo-Qin Fu; Yu Tong; Zhen Wang; Wei-Fen Li; Xiao-Zhou Mou
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 2.  Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer.

Authors:  Mehdi Chaib; Subhash C Chauhan; Liza Makowski
Journal:  Front Cell Dev Biol       Date:  2020-05-19

3.  Identification of Iron Metabolism-Related Gene Signatures for Predicting the Prognosis of Patients With Sarcomas.

Authors:  Jianyi Li; Chuan Hu; Yukun Du; Xiaojie Tang; Cheng Shao; Tongshuai Xu; Zheng Zhao; Huiqiang Hu; Yingyi Sheng; Jianwei Guo; Yongming Xi
Journal:  Front Oncol       Date:  2021-01-07       Impact factor: 6.244

Review 4.  Research trends in pharmacological modulation of tumor-associated macrophages.

Authors:  Neng Wang; Shengqi Wang; Xuan Wang; Yifeng Zheng; Bowen Yang; Juping Zhang; Bo Pan; Jianli Gao; Zhiyu Wang
Journal:  Clin Transl Med       Date:  2021-01

5.  Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer.

Authors:  Yu Liu; Wenting Shang; Heng Liu; Hui Hui; Jun Wu; Wei Zhang; Pengli Gao; Kunxiong Guo; Yanli Guo; Jie Tian
Journal:  J Nanobiotechnology       Date:  2022-01-24       Impact factor: 10.435

6.  M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT.

Authors:  Yingwei Xie; Zhiliang Chen; Qiyu Zhong; Zaosong Zheng; Yuqing Chen; Wentai Shangguan; Yishan Zhang; Jingying Yang; Dingjun Zhu; Wenlian Xie
Journal:  Cancer Cell Int       Date:  2021-12-18       Impact factor: 5.722

Review 7.  From Microenvironment Remediation to Novel Anti-Cancer Strategy: The Emergence of Zero Valent Iron Nanoparticles.

Authors:  Ya-Na Wu; Li-Xing Yang; Pei-Wen Wang; Filip Braet; Dar-Bin Shieh
Journal:  Pharmaceutics       Date:  2022-01-02       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.